All Posts
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
Study Name Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer ClinicalTrials.gov…
Webinar: CCF & Ciitizen-Take Control of Your Health Data
On August 12, the Cholangiocarcinoma Foundation announced a partnership with Ciitizen. This partnership is formed around the belief that you…
PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations
Study Name PROOF Trial: Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations…
Michelle's Hot Peeps Beat CC
Over 150 runners braved the Texas heat in Taylor, TX, on Saturday, Aug. 10th, to support the second annual “Michelle’s…
Repurposing Drugs for Cholangiocarcinoma
Over three years ago I was diagnosed with an incurable cancer, at the age of just 39 when my 3…
Cholangiocarcinoma Foundation Awards $365k in Research Fellowship Grants in Largest Funding Cycle to Date
Since 2015, the Foundation has awarded more than $1.9 million in funding for innovative, high-quality research. SALT LAKE CITY, UTAH,…
Cholangiocarcinoma Foundation Awards $365k in Research Fellowship Grants in Largest Funding Cycle to Date
Read the full article by clicking here.
The Cancerbet – or What Cancer Does and Does NOT do – from A to Z
A Cancer AGES us but isn’t aging what we long for?! B It BLINDS us to far away, future concerns. It brings us to…
Martha Ann Auble Alderman
Martha Ann Auble Alderman passed away peacefully in her sleep on Wednesday, July 31 after a brief, but hard-fought battle…
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Study Name Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene ClinicalTrials.gov Identifier…